Proteomic analysis of human prostate cancer

被引:114
作者
Ahram, M
Best, CJM
Flaig, MJ
Gillespie, JW
Leiva, IM
Chuaqui, RF
Zhou, G
Shu, HJ
Duray, PH
Linehan, WM
Raffeld, M
Ornstein, DK
Zhao, YM
Petricoin, EF
Emmert-Buck, MR
机构
[1] NCI, Pathogenet Unit, Pathol Lab, NIH, Bethesda, MD 20892 USA
[2] NCI, Urol Oncol Branch, NIH, Bethesda, MD 20892 USA
[3] NCI, Sci Applicat Int Corp, NIH, Bethesda, MD 20892 USA
[4] Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75235 USA
[5] NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA
[6] NCI, Urol Oncol Branch, NIH, Bethesda, MD 20892 USA
[7] Univ N Carolina, Dept Urol, Chapel Hill, NC USA
[8] US FDA, Ctr Biol Evaluat & Res, Tissue Proteom Unit, Bethesda, MD USA
关键词
prostate cancer; proteomics; microarray; microdissection; heterogeneity;
D O I
10.1002/mc.10019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Proteomics is a promising approach in the identification of proteins and biochemical pathways involved in tumorigenesis. In an effort to discover such proteins and pathways that are deregulated in prostate tumorigenesis, cellular proteomes of matched normal prostate epithelial cells and high-grade prostate cancer cells were analyzed by tissue microdissection, two-dimensional electrophoresis, and mass spectrometry. Forty protein alterations were detected in the tumors; however, the majority of these charges were not shared among the 12 neoplasms. In contrast, parallel cDNA microarray analysis identified a number of common gene expression changes. The marked heterogeneity of the observed protein alterations may have significance with regard to tumor biology and research strategies for molecular profiling analyses of human prostate cancer. Published 2002 Wiley-Liss, Inc.(dagger)
引用
收藏
页码:9 / 15
页数:7
相关论文
共 26 条
  • [1] Polypeptide expression in prostate hyperplasia and prostate adenocarcinoma
    Alaiya, A
    Roblick, U
    Egevad, L
    Carlsson, A
    Franzén, B
    Volz, D
    Huwendiek, S
    Linder, S
    Auer, G
    [J]. ANALYTICAL CELLULAR PATHOLOGY, 2000, 21 (01): : 1 - 9
  • [2] Identification of proteins in human prostate tumor material by two-dimensional gel electrophoresis and mass spectrometry
    Alaiya, AA
    Oppermann, M
    Langridge, J
    Roblick, U
    Egevad, L
    Brändstedt, S
    Hellström, M
    Linder, S
    Bergman, T
    Jörnvall, H
    Auer, G
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2001, 58 (02) : 307 - 311
  • [3] Proteome and proteomics: New technologies, new concepts, and new words
    Anderson, NL
    Anderson, NG
    [J]. ELECTROPHORESIS, 1998, 19 (11) : 1853 - 1861
  • [4] Banks RE, 1999, ELECTROPHORESIS, V20, P689, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<689::AID-ELPS689>3.0.CO
  • [5] 2-J
  • [6] Gene expression profiling:: monitoring transcription and translation products using DNA microarrays and proteomics
    Celis, JE
    Kruhoffer, M
    Gromova, I
    Frederiksen, C
    Ostergaard, M
    Thykjaer, T
    Gromov, P
    Yu, JS
    Pálsdóttir, H
    Magnusson, N
    Orntoft, TF
    [J]. FEBS LETTERS, 2000, 480 (01) : 2 - 16
  • [7] Human and mouse proteomic databases: novel resources in the protein universe
    Celis, JE
    Ostergaard, M
    Jensen, NA
    Gromova, I
    Rasmussen, HH
    Gromov, P
    [J]. FEBS LETTERS, 1998, 430 (1-2): : 64 - 72
  • [8] The genetics of cancer - a 3D model
    Cole, KA
    Krizman, DB
    Emmert-Buck, MR
    [J]. NATURE GENETICS, 1999, 21 (Suppl 1) : 38 - 41
  • [9] DeRisi J, 1996, NAT GENET, V14, P457
  • [10] Emmert-Buck MR, 2000, MOL CARCINOGEN, V27, P158, DOI 10.1002/(SICI)1098-2744(200003)27:3<158::AID-MC2>3.0.CO